• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Galectin Therap(GALT.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec18
Fund L.P. 10X Sells Galectin Therapeutics Shares
16:44
Dec5
Galectin Therapeutics Inc. Releases New Data on Galectin-3 Inhibitor Belapectin
21:15
Nov15
Galectin Therap released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.128 (forecast USD -0.11)
04:00
Galectin Therap released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.4015
04:00
Nov10
Galectin Therapeutics Reports Positive Results for Belapectin in MASH Liver Disease 2b Phase NAVIGATE Trial
12:57
Aug15
Galectin Therap released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2714
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.223 M, EPS -0.128

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.584 M, EPS -0.1195

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.605 M, EPS -0.1519

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
86.850
+258.88%
+62.650
NBY
19.160
+102.54%
+9.700
VLN
2.480
+58.97%
+0.920
GP
1.240
+51.04%
+0.419
ATGL
30.610
+46.96%
+9.781
OPAD
2.190
+44.08%
+0.670
VCIG
0.9601
+41.00%
+0.279
THH
29.470
+36.31%
+7.850
APLX
113.630
+35.44%
+29.730
ZNTL
3.740
+31.69%
+0.900
View More